MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

1.650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cerus Corporation - Common Stock

< Previous 1 2 3 4 Next >
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
From Cerus Corporation
Via Business Wire
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Second Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
From Cerus Corporation
Via Business Wire
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
From Cerus Corporation
Via Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces First Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Third Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
From Cerus Corporation
Via Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2024
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story